Food and Drug Administration, Healthcare Provider, Leads and Pharmaceutical products

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Food and Drug Administration

Healthcare Provider

Leads

Pharmaceutical products

Economics and risks of FDA’s Quality management maturity rating programme

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing

Uri Goren

Cadensee

JULY 20, 2021

It might be silly question but bringing a drug to market takes many, many years. So, do you listen to them at the point when a pharma company decides what drug it needs to make? Do you listen to them to improve your marketing and the way they should take the drug or the drug should be administered and so on so forth?

Food and Drug Administration

Food and Drug Administration Doctors Healthcare Healthcare

Pharma Rep Focus

Economics and risks of FDA’s Quality management maturity rating programme

Uri Goren

Stay Connected